De-escalation of antiplatelet therapy after percutaneous coronary intervention among East Asians and non-East Asians: a meta-analysis of randomized controlled trials

Overview of attention for article published in BMC Cardiovascular Disorders, February 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 1 X users, with an upper bound of 12,874 followers.

RT @tak_pom: https://t.co/Ri7N6f63A1 De-escalation of antiplatelet therapy after percutaneous coronary intervention among East Asians and…

17 Oct 2022

Reply Repost Favourite

https://t.co/Ri7N6f63A1 De-escalation of antiplatelet therapy after percutaneous coronary intervention among East Asians and non-East Asians: a meta-analysis of randomized controlled trials BMC Cardiovasc Disord. 2022; 22: 29.

28 Jun 2022

Reply Repost Favourite

RT @tak_pom: De-escalation of antiplatelet therapy after percutaneous coronary intervention among East Asians and non-East Asians: a meta-a…

27 Jun 2022

Reply Repost Favourite

De-escalation of antiplatelet therapy after percutaneous coronary intervention among East Asians and non-East Asians: a meta-analysis of randomized controlled trials BMC Cardiovasc Disord. 2022; 22: 29. https://t.co/Ri7N6f63A1

25 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.